Author:
Momot Simon L.,Agustarika Butet,Mustamu Alva Cherry,Sari Nurul Kartika
Abstract
BACKGROUND: Chronic kidney disease is closely related to diabetes. Basic information about the treatment and physical condition of diabetic patients should be analyzed to provide further evidence of prevention. Based on the high prevalence of diabetes mellitus (DM) among patients with renal failure, there is a great need to learn more about its prevention and management including laboratory diagnostic tests because HbA1c levels are directly proportional to blood glucose levels.
AIM: The purpose of this study was to determine the effect of HbA1c levels on creatinine levels in patients with Type 2 DM.
METHODS: This type of research is a quantitative study with a cross-sectional approach. The sample in this study was 38 DM patients who had their diagnosis confirmed using consecutive sampling techniques. According to the healthcare centre’s data, the respondent’s blood sample was taken at the respondent’s house, and the HbA1c and creatinine levels were tested in the laboratory. Data analysis using the Chi-square test.
RESULTS: The results of this study indicate that there is no relationship between HbA1c levels and the incidence of kidney failure with p = 0.588, OR 0.658.
CONCLUSION: This research showed that there was no relationship between HbA1c levels with the incidence of kidney failure.
Publisher
Scientific Foundation SPIROSKI
Reference34 articles.
1. Abate TW, Dessie G, Workineh Y, Gedamu H, Birhanu M, Ayalew E, et al. Non-adherence to self-care and associated factors among diabetes adult population in Ethiopian: A systemic review with meta-analysis. PLoS One. 2021;16:e0245862. http://doi.org/10.1371/journal.pone.0245862 PMid:335668612
2. Badan Penelitian dan Pengembangan Kesehatan RI. RISKESDAS Tahun 2018. Available from: https://www.labmandat.litbang.kemkes.go.id/riset-badan-litbangkes/menu-riskesnas/menu-riskesdas/426-rkd-2018. [Last accessed on 2021 Aug 21].
3. Ackermann RT, Kang R, Cooper AJ, Liss DT, Holmes AM, Moran M, et al. Effect on health care expenditures during nationwide implementation of the diabetes prevention program as a health insurance benefit. Diabetes Care. 2019;42(9):1776-83. http://doi.org/10.2337/dc18-2071 PMid:310108701
4. ADA. The Cost of Diabetes, ADA; 2020. Available from: https://www.diabetes.org/resources/statistics/cost-diabetes. [Last accessed on 2021 Aug 21].
5. Ahmed Z, Prasad I, Rahman H, Ansari J, Hassan K. A male with extreme subcutaneous insulin resistance: A case report. Roman J Diabetes Nutr Metab Dis. 2016;23(2):209-13. https://doi.org/10.1515/rjdnmd-2016-0025 PMid:27917299